文献速递真菌感染

念珠菌、曲霉和隐球菌的抗真菌药敏试验:MIC对临床医生有用吗?

Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?
PubMed 文献 · Clin Microbiol Infect · 2020-02-29

该综述基于PubMed检索及个人文献收藏,评估念珠菌、曲霉和隐球菌耐药流行病学及MIC对侵袭性真菌感染患者临床结局的影响。研究显示耐药与抗真菌治疗反应较差相关,但合并症、感染性休克和感染来源等宿主因素也是影响结局的关键决定因素。未来需国际合作研究以明确体外耐药对患者结局的相对贡献。

要点

  • 耐药真菌分离株与治疗反应较差相关,但宿主因素影响更大。
  • 合并症、感染性休克和感染来源是影响侵袭性真菌感染结局的关键因素。
  • 需国际合作研究量化体外耐药对临床结局的相对贡献。

核心结论

  • 尽管耐药与抗真菌治疗反应较差相关,但合并症、感染性休克和感染来源等宿主因素似乎是影响侵袭性真菌感染患者临床结局的关键决定因素。

研究设计与样本

  • 综述,通过PubMed检索相关关键词并结合个人文献收藏,评估念珠菌、曲霉和隐球菌耐药流行病学及MIC对临床结局影响的文献。

主要发现

  • 耐药真菌分离株(如念珠菌、曲霉和隐球菌)的流行病学被更新,显示唑类或棘白菌素MIC升高的耐药分离株已有报道。
  • 多项研究中抗真菌耐药与抗真菌治疗反应较差相关,但合并症、感染性休克和感染来源等因素也影响临床结局。

临床怎么用

  • 临床医生应综合考量MIC结果与宿主因素(如合并症、感染性休克、感染来源)来评估侵袭性真菌感染患者的预后和管理。

局限性

  • 需未来国际协作研究以区分体外抗真菌耐药对患者结局的相对贡献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Invasive fungal infections (IFIs) represent a global issue and affect various patient populations. In recent years, resistant fungal isolates showing increased azole or echinocandin MICs have been reported, and their potential clinical impact has been investigated. AIMS: To provide an update on the epidemiology of resistance among fungi (e.g., Candida spp., Aspergillus spp., and Cryptococcus spp.) and to offer a critical appraisal of the relevant literature regarding the impact of MICs on clinical outcome in patients with IFI. SOURCES: PubMed search with relevant keywords along with a personal collection of relevant publications. CONTENT: Although antifungal resistance has been associated with a poorer response to antifungal therapy in various studies, other factors such as comorbidities, septic shock and source of infection appear to be key determinants affecting the clinical outcome of patients with IFI. IMPLICATIONS: Future international collaborative studies are required to tease out the relative contribution of in vitro antifungal resistance on patient outcomes, thus enabling the optimization of IFI management.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Bassetti M, Vena A, Bouza E, et al. Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians? Clin Microbiol Infect. 2020. PMID: 32120042. doi:10.1016/j.cmi.2020.02.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。